Syros Pharmaceuticals Inc. buy Piper Sandler
Start price
13.08.24
/
50%
€1.76
Target price
13.08.25
€4.56
Performance (%)
-94.20%
End price
14.08.25
-
Summary
This prediction is currently being closed. Massive losses of -94.20% have been the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Syros Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -1.764% | 2.259% | 15.847% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 4.686% |
| iShares Nikkei 225® | -2.451% | 4.086% | 16.083% |
| iShares S&P 500 | -2.252% | -0.151% | 1.636% |
Comments by Piper_Sandler for this prediction
In the thread Syros Pharmaceuticals Inc. diskutieren
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $5.00 price target on the stock, down previously from $13.00.
Ratings data for SYRS provided by MarketBeat
In the thread Trading Syros Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.58
03.04.24
03.04.24
€12.01
03.04.25
03.04.25
-97.77%
04.04.25
04.04.25
